Oric Pharmaceuticals, Inc. — Director's Dealing 2021

May 19, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oric Pharmaceuticals, Inc. (ORIC)
CIK: 0001796280
Period of Report: 2021-05-14

Reporting Person: Heyman Richard A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-14	Common Stock	S	3215	$25.3133	Disposed	223885	Indirect
2021-05-17	Common Stock	S	498	$25.0679	Disposed	223387	Indirect
2021-05-18	Common Stock	S	2161	$25.3195	Disposed	221226	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12500	Direct

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by RAHD Capital, LLC.

F2: Represents the weighted average share price of an aggregate total of 3,215 shares sold in the price range of $25.00 to $25.83 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

F4: Represents the weighted average share price of an aggregate total of 498 shares sold in the price range of $25.00 to $25.14 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5: Represents the weighted average share price of an aggregate total of 2,161 shares sold in the price range of $25.00 to $25.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.